World Alzheimer Report 2018

The World Alzheimer Report 2018, The state of the art of dementia research: New frontiers brings together 21 of the global leading lights in all areas of dementia research. Written by renowned journalist and broadcaster Christina Patterson (Time Magazine, The Guardian, The Sunday Times), this report tackles some of the complex questions surrounding dementia research. It looks at the hopes and frustrations and asks why there have been no major medical treatment breakthroughs for over 20 years.

The report looks at a broad cross section of research areas including basic science; diagnosis; drug discovery; risk reduction and epidemiology. With the continued absence of a disease modifying treatment, the report also features progress, innovation and developments in care research.

The report highlights an urgent need for increased and sustainable funding for dementia research. The global ratio of publications on neurodegenerative disorders, versus cancer, is an astonishing 1:12. Through this report Alzheimer’s Disease International is calling on governments to commit to a minimum of 1% of the societal cost of dementia to be dedicated to research. In 2018 the global societal cost is US$1 trillion.

A full list of interviewees can be found on page 46 of the report.

El Informe Mundial sobre el Alzheimer 2018 en español

El Informe Mundial sobre el Alzheimer 2018 - La investigación de vanguardia sobre la demencia: nuevas fronteras reúne 21 de los actores principales a nivel mundial en todas las áreas de investigación de la demencia. Escrito por la reconocida periodista y locutora Christina Patterson, este informe aborda algunas de las preguntas complejas que rodean la investigación de la demencia. Analiza las esperanzas y frustraciones y pregunta por qué no han habido avances importantes en el tratamiento médico durante más de 20 años.

El informe destaca la necesidad urgente de un mayor y sostenible financiamiento para la investigación de la demencia. La proporción global de publicaciones sobre trastornos neurodegenerativos versus aquellas sobre cáncer, es de un asombrosa 1:12. A través de este informe, Alzheimer’s Disease internacional está pidiendo a los gobiernos que se comprometan a un mínimo del 1% del costo social de la demencia para dedicarse a la investigación.

Read the report

Additional Materials